Search Results for:
-
Bench Press
Their work appeared in the March 7, 2012, issue of Neuron. – By Anette Breindl, Science EditorBioWorld Today | Monday, March 12, 2012 -
PTEN Extends Mouse Life Span, Partly via Affecting Metabolism
By Anette Breindl Science Editor A team of researchers has shown that transgenic mice with increased levels of the tumor suppressor PTEN have a longer life span than their wild-type brethrenBio Perspectives | Wednesday, March 7, 2012 -
Bench Press
Helper T Cells Are Killers in HIV HIV infects CD4 "helper" T cells. But new research out of the Massachusetts Institute of Technology's Ragon Institute showed that early in the course of HIV infection, helper T cells play a greater role in controlling the disease than has been appreciated. Specifically, they are able to directly recognize and kill HIV-infected cells. The authors found that patients with more HIV-specific T cells were able to control HIV infection well into the course of theBioWorld Today | Monday, March 5, 2012 -
Translational Profiling Suggests How to Judge, Use Cancer Drug
By Anette Breindl Science Editor By focusing on protein translation, scientists have gained surprising insights into the control of prostate cancer metastasis, linking it to dysregulation of the protein kinase mTORBio Perspectives | Tuesday, February 28, 2012 -
Bench Press
Genes Are Overrated... A multinational team led by scientists from the British Wellcome Trust Sanger Institute has systematically tested how frequent loss-of-function mutations are in the human genome – and has come to the conclusion that they are surprisingly common. Based on their sequencing, the scientists estimated that the average human genome contains 100 loss-of-function variants and 20 completely inactivated genes. The authors compared 200 genes that are loss-of-function tolerantBioWorld Today | Monday, February 27, 2012 -
Bench Press
Blind Men and the Elephant Three separate papers last week reported different new insights into isocitrate dehydrogenase 1, or IDH1, an enzyme that is critical in the altered metabolism of cancer cells. Two papers came out of Memorial Sloan-Kettering Cancer Center, the third out of the Dana-Farber Cancer Institute. Two papers linked mutations in IDH1 to changes in cell methylation in gliomas, which in turn prevented progenitor-like cells from fully differentiating. The third paper showed thatBioWorld Today | Tuesday, February 21, 2012 -
Eisai Lymphoma Drug Reverses Alzheimer's Disease Symptoms
By Anette Breindl Science Editor Researchers identified a drug which, in animals, rapidly decreases both plaque area and soluble amyloid beta levels in mouse models of Alzheimer's diseaseBio Perspectives | Tuesday, February 14, 2012 -
Bench Press
Both of those papers were published in the Feb. 9, 2012, issue of Nature. – By Anette Breindl, Science EditorBioWorld Today | Monday, February 13, 2012 -
Resveratrol's Effects On Sirtuins May Be Mimicked by COPD Drug
By Anette Breindl Science Editor Resveratrol, a compound found in minuscule doses in foods including red wine and chocolate, is as close to ambrosia – the food of the ancient Greek Gods that gave them eternal youth – as anyone has comeBio Perspectives | Wednesday, February 8, 2012 -
'Productive Areas of Overlap,' Conflicts for Academia, Industry
By Anette Breindl Science Editor In a session on "Bridging the Valley of Death: How Can Academia and Pharma Best Work TogetherBio Perspectives | Wednesday, February 8, 2012 -
Bench Press
How the Leg Causes Trouble for the Brain Researchers from the Japanese Osaka University have uncovered an unexpected mechanism by which autoimmune T cells cross the blood-brain barrier in mice with the animal equivalent of multiple sclerosis. The authors found the cells crossed over at one particular level of the spinal cord. The reason they were able to do so was that activation of a leg muscle, the soleus muscle, caused chemokines to be released. Those released proinflammatory chemokinesBioWorld Today | Monday, February 6, 2012 -
Side Effects Data, Too, Impress for New Prostate Cancer Drugs
By Anette Breindl Science Editor Only two weeks after disappointing news on its Alzheimer's disease candidate, Dimebon (latrepirdine), Medivation IncBio Perspectives | Wednesday, February 1, 2012 -
Bench Press
Doc, I Need Levitra for My Ears Elders shouting at today's young to do as they say, not as they did during the heyday of rock, may have a point: Noise-induced hearing loss is on the rise. A phenomenon," wrote scientists at the German University of Tuebingen, "possibly connected to the negligent use of portable audio players." But those same researchers offered a possible strategy to protect the ears. By treating mice with Levitra (vardenafil, GlaxoSmithKline plc) they were able to prevent noiseBioWorld Today | Monday, January 30, 2012 -
Bench Press
Longevity Data: Retracted, Reanalyzed, Republished Scientists from Boston University have reanalyzed and republished data on genetic signatures of exceptional longevity that were first published in 2010, and then retracted over methodological concerns. In the original work, the authors identified a gene signature of about 150 SNPs that predicted a long life span and health span for those individuals who possessed it. Notably, disease risk variants such as the Alzheimer's ApoE4 variant were asBioWorld Today | Monday, January 23, 2012 -
Taking Out Cancer Stem Cells Won't Be Enough, Study Hints
By Anette Breindl Science Editor Cancer treatment is a field that has seen impressive advances in many areas, but no home run in terms of a cureBio Perspectives | Wednesday, January 18, 2012 -
Bench Press
UnDOCumented Parasites Can't Cross Cellular Borders Apicomplexan parasites – a group that includes both the malaria and the toxoplasmosis parasite – use organelles called micronemes to get themselves into and out of the host cells where they replicate. Scientists from Boston College discovered that mutations in one protein of the complex, DOC2.1, are impaired at entering and exiting cells. In their work, the authors began by isolating a form of toxoplasmosis that is impaired at entering cellsBioWorld Today | Tuesday, January 17, 2012 -
Bench Press
The paper describing the experiments appeared in the Jan. 1, 2012, issue of Cancer Research. – Anette Breindl, Science EditorBioWorld Today | Monday, January 9, 2012 -
Study: Late Sepsis Comes With Immunosuppression
By Anette Breindl Science Editor Sepsis is widely believed to be due to an out-of-control inflammatory response, and efforts to develop drugs to treat that condition have focused on reining in the immune systemBio Perspectives | Tuesday, January 3, 2012 -
Bench Press
The work appeared in the Dec. 19, 2011, online edition of the Journal of Clinical Investigation. – Anette Breindl, Science EditorBioWorld Today | Tuesday, January 3, 2012 -
Bench Press
Their paper was published in the Dec. 19, 2011, online edition of the Journal of Clinical Investigation. – Anette Breindl, Science EditorBioWorld Today | Tuesday, December 27, 2011
Category
Current Filters
- xScience Editor
Related Keywords
Categories
- x BioWorld Today (3420)
- x Bio Perspectives (157)
- x BioWorld Insight (18)
- x BioWorld International (16)
- x State of the Industry Report (12)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.